The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis
Open accessAbstract
Atherosclerosis is an inflammatory vascular disease responsible for the first cause of mortality worldwide. Recent studies have clearly highlighted the critical role of the immunoinflammatory balance in the modulation of disease development and progression. However, the immunoregulatory pathways that control atherosclerosis remain largely unknown. We show that loss of suppressor of cytokine signaling (SOCS) 3 in T cells increases both interleukin (IL)-17 and IL-10 production, induces an antiinflammatory macrophage phenotype, and leads to unexpected IL-17–dependent reduction in lesion development and vascular inflammation. In vivo administration of IL-17 reduces endothelial vascular cell adhesion molecule–1 expression and vascular T cell infiltration, and significantly limits atherosclerotic lesion development. In contrast, overexpression of SOCS3 in T cells reduces IL-17 and accelerates atherosclerosis. We also show that in human lesions, increased levels of signal transducer and activator of transcription (STAT) 3 phosphorylation and IL-17 are associated with a stable plaque phenotype. These results identify novel SOCS3-controlled IL-17 regulatory pathways in atherosclerosis and may have important implications for the understanding of the increased susceptibility to vascular inflammation in patients with dominant-negative STAT3 mutations and defective Th17 cell differentiation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The immune response in atherosclerosis: a double-edged sword
Hansson, G. K., & Libby, P. (2006) · Nature Reviews Immunology · doi:10.1038/nri1882 · Cited by 2,182
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Self-citationSOCS proteins, cytokine signalling and immune regulation
Yoshimura, A., Naka, T., & Kubo, M. (2007) · Nature Reviews Immunology · doi:10.1038/nri2093 · Cited by 1,580
Self-citationTH-17 cells in the circle of immunity and autoimmunity
Bettelli, E., Oukka, M., & Kuchroo, V. K. (2007) · Nature Immunology · doi:10.1038/ni0407-345 · Cited by 1,517
Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome
Milner, J. D., Brenchley, J. M., Laurence, A., Freeman, A. F., Hill, B. J., Elias, K. M., Kanno, Y., Spalding, C., Elloumi, H. Z., Paulson, M. L., et al. (2008) · Nature · doi:10.1038/nature06764 · Cited by 1,157
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
Wang, T., Niu, G., Kortylewski, M., Burdelya, L., Shain, K., Zhang, S., Bhattacharya, R., Gabrilovich, D., Heller, R., Coppola, D., et al. (2004) · Nature Medicine · doi:10.1038/nm976 · Cited by 1,155
TH17 cells in development: an updated view of their molecular identity and genetic programming
Dong, C. (2008) · Nature reviews. Immunology · doi:10.1038/nri2295 · Cited by 1,064 · cited 3×
“However, we also detected a threefold increase in IL17 production by the purified SOCS3deficient CD4+ cells compared with controls, consistent with the critical role of STAT3 activation in Th17 development (Fig. 1 c; Chen et al. 2006; Dong, 2008).”
Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome
Minegishi, Y., Saito, M., Tsuchiya, S., Tsuge, I., Takada, H., Hara, T., Kawamura, N., Ariga, T., Pasic, S., Stojkovic, O., et al. (2007) · Nature · doi:10.1038/nature06096 · Cited by 1,048
The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models
Weber, C., Zernecke, A., & Libby, P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2415 · Cited by 776
IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages
Yasukawa, H., Ohishi, M., Mori, H., Murakami, M., Chinen, T., Aki, D., Hanada, T., Takeda, K., Akira, S., Hoshijima, M., et al. (2003) · Nature Immunology · doi:10.1038/ni938 · Cited by 771
Self-citationSelective regulatory function of Socs3 in the formation of IL-17-secreting T cells
Chen, Z., Laurence, A., Kanno, Y., Pacher-Zavisin, M., Zhu, B.-M., Tato, C., Yoshimura, A., Hennighausen, L., & O'Shea, J. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600666103 · Cited by 653
Self-citationDeficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3
Ma, C. S., Chew, G. Y. J., Simpson, N., Priyadarshi, A., Wong, M., Grimbacher, B., Fulcher, D. A., Tangye, S. G., & Cook, M. C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080218 · Cited by 652
Innate and acquired immunity in atherogenesis
Binder, C. J., Chang, M.-K., Shaw, P. X., Miller, Y. I., Hartvigsen, K., Dewan, A., & Witztum, J. L. (2002) · Nature Medicine · doi:10.1038/nm1102-1218 · Cited by 642
Interleukin-17 is a negative regulator of established allergic asthma
Schnyder-Candrian, S., Togbe, D., Couillin, I., Mercier, I., Brombacher, F., Quesniaux, V., Fossiez, F., Ryffel, B., & Schnyder, B. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061401 · Cited by 564
In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORγt+ T cells
Lochner, M., Peduto, L., Cherrier, M., Sawa, S., Langa, F., Varona, R., Riethmacher, D., Si-Tahar, M., Di Santo, J. P., & Eberl, G. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080034 · Cited by 542
Eid, R. E., Rao, D. A., Zhou, J., Lo, S.-F. L., Ranjbaran, H., Gallo, A., Sokol, S. I., Pfau, S., Pober, J. S., & Tellides, G. (2009) · Circulation · doi:10.1161/circulationaha.108.827618 · Cited by 412
SOCS-3 regulates onset and maintenance of TH2-mediated allergic responses
Seki, Y.-I., Inoue, H., Nagata, N., Hayashi, K., Fukuyama, S., Matsumoto, K., Komine, O., Hamano, S., Himeno, K., Inagaki-Ohara, K., et al. (2003) · Nature Medicine · doi:10.1038/nm896 · Cited by 362
Self-citationRationale and design: PRiSM Psychosis Study 1
Thornicroft, G., Strathdee, G., Phelan, M., Holloway, F., Wykes, T., Dunn, G., McCrone, P., Leese, M., Johnson, S., & Szmukler, G. (1998) · British Journal of Psychiatry · doi:10.1192/bjp.173.5.363 · Cited by 319
Mallat, Z., Gojova, A., Brun, V., Esposito, B., Fournier, N., Cottrez, F., Tedgui, A., & Groux, H. (2003) · Circulation · doi:10.1161/01.cir.0000089083.61317.a1 · Cited by 306
Self-citationMaron, R., Sukhova, G., Faria, A.-M., Hoffmann, E., Mach, F., Libby, P., & Weiner, H. L. (2002) · Circulation · doi:10.1161/01.cir.0000029750.99462.30 · Cited by 267
Lactadherin Deficiency Leads to Apoptotic Cell Accumulation and Accelerated Atherosclerosis in Mice
Ait-Oufella, H., Kinugawa, K., Zoll, J., Simon, T., Boddaert, J., Heeneman, S., Blanc-Brude, O., Barateau, V., Potteaux, S., Merval, R., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.662080 · Cited by 255
Self-citationVerhoeven, B. A. N., Velema, E., Schoneveld, A. H., Vries, J. P. P. M. D., de Bruin, P., Seldenrijk, C. A., Kleijn, D. P. V. D., Busser, E., der Graaf, Y. V., Mol, F., et al. (2004) · European Journal of Epidemiology · doi:10.1007/s10564-004-2304-6 · Cited by 245
Self-citationKinjyo, I., Inoue, H., Hamano, S., Fukuyama, S., Yoshimura, T., Koga, K., Takaki, H., Himeno, K., Takaesu, G., Kobayashi, T., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052333 · Cited by 225
Self-citationTanaka, K., Ichiyama, K., Hashimoto, M., Yoshida, H., Takimoto, T., Takaesu, G., Torisu, T., Hanada, T., Yasukawa, H., Fukuyama, S., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.3746 · Cited by 187
Self-citationIL-17 produced by Paneth cells drives TNF-induced shock
Takahashi, N., Vanlaere, I., de Rycke, R., Cauwels, A., Joosten, L. A. B., Lubberts, E., van den Berg, W. B., & Libert, C. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080588 · Cited by 182
Causes of death in hyper-IgE syndrome
Freeman, A. F., Kleiner, D. E., Nadiminti, H., Davis, J., Quezado, M., Anderson, V., Puck, J. M., & Holland, S. M. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.12.666 · Cited by 172
Taleb, S., Herbin, O., Ait‐Oufella, H., Verreth, W., Gourdy, P., Barateau, V., Merval, R., Esposito, B., Clément, K., Holvoet, P., et al. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.149567 · Cited by 172
Self-citationDevelopment of an anti‐IL‐17A auto‐vaccine that prevents experimental auto‐immune encephalomyelitis
Uyttenhove, C., & Snick, J. V. (2006) · European Journal of Immunology · doi:10.1002/eji.200636662 · Cited by 154
Self-citationGharavi, N. M., Alva, J. A., Mouillesseaux, K. P., Lai, C. K., Yeh, M. W., Yeung, W., Johnson, J. P., Szeto, W. L., Hong, L., Fishbein, M. C., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704267200 · Cited by 142
Suppressors of Cytokine Signaling Modulate JAK/STAT-Mediated Cell Responses During Atherosclerosis
Ortiz-Muñoz, G., Martín-Ventura, J. L., Hernández-Vargas, P., Mallavia, B., López-Parra, V., López‐Franco, Ó., Muñoz‐García, B., Fernández‐Vizarra, P., Ortega, L. M., Egido, J., et al. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.173781 · Cited by 125
Hellings, W. E., Pasterkamp, G., Vollebregt, A. M., Seldenrijk, C. A., de Vries, J. P. P. M., Velema, E., de Kleijn, D. P. V., & Moll, F. L. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2007.08.018 · Cited by 92
Self-citationCoronary artery aneurysms in patients with hyper IgE recurrent infection syndrome
Ling, J. C., Freeman, A. F., Gharib, A. M., Arai, A. E., Lederman, R. J., Rosing, D. R., & Holland, S. M. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.10.005 · Cited by 76
Tang, J., Kozaki, K., Farr, A. G., Martin, P. J., Lindahl, P., Betsholtz, C., & Raines, E. W. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62061-5 · Cited by 55
Uyttenhove, C., Sommereyns, C., Théate, I., Michiels, T., & Snick, J. V. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1423.035 · Cited by 43
Self-citationAge and gender effects on apoptosis in the human coronary arterial wall
Boddaert, J., Mallat, Z., Fornés, P., Esposito, B., Lecomte, D., Verny, M., Tedgui, A., & Belmin, J. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.01.001 · Cited by 15
Self-citation
Cited by
Progress and challenges in translating the biology of atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2011) · Nature · doi:10.1038/nature10146 · Cited by 4,010
The immune system in atherosclerosis
Hansson, G. K., & Hermansson, A. (2011) · Nature Immunology · doi:10.1038/ni.2001 · Cited by 2,317
Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
Kong, P., Cui, Z.-Y., Huang, X.-F., Zhang, D.-D., Guo, R.-J., & Han, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00955-7 · Cited by 1,183
Th17 and regulatory T cells in mediating and restraining inflammation
Littman, D. R., & Rudensky, A. Y. (2010) · Cell · doi:10.1016/j.cell.2010.02.021 · Cited by 1,039
The immunology of atherosclerosis
Gisterå, A., & Hansson, G. K. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.51 · Cited by 982
Metadata
- Authors
- Taleb, S., Romain, M., Ramkhelawon, B., Uyttenhove, C., Pasterkamp, G., Herbin, O., Esposito, B., Perez, N., Yasukawa, H., Van Snick, J., Yoshimura, A., Tedgui, A., & Mallat, Z.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2009-09-08
- Volume
- 206
- Issue
- 10
- Pages
- 2067-2077
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2143786724
- Cited by
- 408
- References
- 35
- FWCI
- 15.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.